Europe — EMA
Obgemsa (Vibegron)
Vibegron, the active ingredient in Obgemsa, is a beta‑3 adrenergic receptor agonist presented as a oral tablet for oral use. It is indicated for the treatment of overactive bladder in adults.
Request sourcing
What is Vibegron?
Vibegron, the active ingredient in Obgemsa, is a beta‑3 adrenergic receptor agonist presented as a oral tablet for oral use. It is indicated for the treatment of overactive bladder in adults. GNH USA supplies Obgemsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Obgemsa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Vibegron used for?
Obgemsa contains vibe‑re‑gon and works on the urinary system pathway to relieve symptoms of overactive bladder.
- Overactive bladder: Improves urgency, frequency and incontinence episodes. - Neurogenic detrusor overactivity: Reduces involuntary bladder contractions. - Mixed urinary incontinence: Helps balance bladder storage function.
What are the side effects of Vibegron?
Adverse reactions reported with vibegron are generally mild to moderate.
Common Side Effects: - Dry mouth - Nasal congestion - Headache - Constipation - Fatigue - Dizziness
Serious or Rare Side Effects: - Hypertension - Urinary retention - Severe allergic reaction (anaphylaxis) - Elevated liver enzymes - Cardiac arrhythmia - Rash with systemic involvement
What precautions apply to Vibegron?
Patients should be aware of several safety considerations when using vibegron.
- Renal impairment: Adjustments may be needed for severe kidney disease. - Hepatic impairment: Use with caution in moderate to severe liver dysfunction. - Cardiovascular disease: Monitor blood pressure and heart rate. - Concomitant anticholinergics: May increase anticholinergic burden. - Pregnancy and lactation: Safety data are limited; avoid unless clearly needed. - Store at ambient temperature: keep in original packaging, protect from moisture.
What does Vibegron interact with?
Vibegron may interact with other medicines, requiring careful monitoring.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors (strong .... .... ... ... .... ... .... ... ... .... ... ) - Concomitant use … .... ... .... … … .... place … … ... ... … t t … …
Moderate t t \n t t ewline ewline ewline ewline ewline ewline ewline ewline ewline \n ");
